Epstein Secrets

e House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, including Modena, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios <https://www.axios.com/us-biden- vaccine-patents-waiver-65478c91-5107-41ff-

ould raise from the wealthy." His plans "are routinely described as big, bold and progressive. This is true but incomplete." What is "really bold," Dionne argues, "is Biden's effort to create a stream of revenue through higher taxes on the wealthy and corporations that would support his efforts on educ

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, induding Moderna, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufact

ould raise from the wealthy." His plans "are routinely described as big, bold and progressive. This is true but incomplete." What is "really bold," Dionne argues, "is Biden's effort to create a stream of revenue through higher taxes on the wealthy and corporations that would support his efforts on educ

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, including Modema, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufac

ould raise from the wealthy." His plans "are routinely described as big, bold and progressive. This is true but incomplete." What is "really bold," Dionne argues, "is Biden's effort to create a stream of revenue through higher taxes on the wealthy and corporations that would support his efforts on educ

s (4/25, Robbins, 20.6M) reports that according to the CDC, "more than five million people, or nearly 8 percent of those who got a first shot of the Pfizer or Moderna vaccines, have missed their second doses." The Times adds that as the US tries to encourage many people to receive a first dose, many he

port in the polls from about a third of Republicans and a substantial majority of lower-income Republicans (in the case of the relief act)." Biden, Dionne writes, "clearly knows what his presidency is about. And he can have confidence that his political strategy and the substance of what he is doing ar